---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-040311"
form_type: "8-K"
ticker: "FEED"
cik: "0001326706"
company_name: "ENvue Medical, Inc."
filed_at: "2024-10-07T23:59:59+00:00"
generated_at: "2026-05-30T19:05:09.882079+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# NanoVibronix sets 2024 annual meeting for Dec 19; shareholder proposal deadline Oct 17

## Summary
- 2024 Annual Meeting of Stockholders scheduled for Thursday, December 19, 2024.
- Record date for voting is close of business on October 28, 2024.
- Deadline for Rule 14a-8 shareholder proposals and director nominations is October 17, 2024.
- Universal proxy rule compliance notice also due by October 17, 2024.
- Meeting date changed by more than 30 days from prior year's anniversary.

## SEC filing metadata
- accession: 0001493152-24-040311
- form_type: 8-K
- ticker: FEED
- cik: 0001326706
- company_name: ENvue Medical, Inc.
- filed_at: 2024-10-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.08
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326706/000149315224040311/0001493152-24-040311-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326706/000149315224040311/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-040311
- JSON: https://secwatch.observer/filing/0001493152-24-040311.json
- Plain text: https://secwatch.observer/filing/0001493152-24-040311.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.